4-N-[5-(1,3-benzodioxol-5-yl)-1H-pyrazol-3-yl]-2-N-[1-(2,4-difluorophenyl)ethyl]-1,3,5-triazine-2,4-diamine;2-N-[1-(2,4-difluorophenyl)ethyl]-4-N-[5-(3,4-dimethoxyphenyl)-1H-pyrazol-3-yl]-1,3,5-triazine-2,4-diamine;2-N-[1-(2,4-difluorophenyl)ethyl]-4-N-[5-(2-fluorophenyl)-1H-pyrazol-3-yl]-1,3,5-triazine-2,4-diamine;2-N-[1-(2,4-difluorophenyl)ethyl]-4-N-[5-(3-fluorophenyl)-1H-pyrazol-3-yl]-1,3,5-triazine-2,4-diamine;2-N-[1-(2,4-difluorophenyl)ethyl]-4-N-[5-(4-fluorophenyl)-1H-pyrazol-3-yl]-1,3,5-triazine-2,4-diamine;2-N-[(1S)-1-(2,4-difluorophenyl)ethyl]-4-N-(5-quinoxalin-6-yl-1H-pyrazol-3-yl)-1,3,5-triazine-2,4-diamine
C125H103F15N44O4 — CID 159964486
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-N-[5-(1,3-benzodioxol-5-yl)-1H-pyrazol-3-yl]-2-N-[1-(2,4-difluorophenyl)ethyl]-1,3,5-triazine-2,4-diamine;2-N-[1-(2,4-difluorophenyl)ethyl]-4-N-[5-(3,4-dimethoxyphenyl)-1H-pyrazol-3-yl]-1,3,5-triazine-2,4-diamine;2-N-[1-(2,4-difluorophenyl)ethyl]-4-N-[5-(2-fluorophenyl)-1H-pyrazol-3-yl]-1,3,5-triazine-2,4-diamine;2-N-[1-(2,4-difluorophenyl)ethyl]-4-N-[5-(3-fluorophenyl)-1H-pyrazol-3-yl]-1,3,5-triazine-2,4-diamine;2-N-[1-(2,4-difluorophenyl)ethyl]-4-N-[5-(4-fluorophenyl)-1H-pyrazol-3-yl]-1,3,5-triazine-2,4-diamine;2-N-[(1S)-1-(2,4-difluorophenyl)ethyl]-4-N-(5-quinoxalin-6-yl-1H-pyrazol-3-yl)-1,3,5-triazine-2,4-diamine
4-N-[5-(1,3-benzodioxol-5-yl)-1H-pyrazol-3-yl]-2-N-[1-(2,4-difluorophenyl)ethyl]-1,3,5-triazine-2,4-diamine;2-N-[1-(2,4-difluorophenyl)ethyl]-4-N-[5-(3,4-dimethoxyphenyl)-1H-pyrazol-3-yl]-1,3,5-triazine-2,4-diamine;2-N-[1-(2,4-difluorophenyl)ethyl]-4-N-[5-(2-fluorophenyl)-1H-pyrazol-3-yl]-1,3,5-triazine-2,4-diamine;2-N-[1-(2,4-difluorophenyl)ethyl]-4-N-[5-(3-fluorophenyl)-1H-pyrazol-3-yl]-1,3,5-triazine-2,4-diamine;2-N-[1-(2,4-difluorophenyl)ethyl]-4-N-[5-(4-fluorophenyl)-1H-pyrazol-3-yl]-1,3,5-triazine-2,4-diamine;2-N-[(1S)-1-(2,4-difluorophenyl)ethyl]-4-N-(5-quinoxalin-6-yl-1H-pyrazol-3-yl)-1,3,5-triazine-2,4-diamine (PubChem CID 159964486) has the molecular formula C125H103F15N44O4 and a molecular weight of 2570.47 g/mol. Its IUPAC name is 4-N-[5-(1,3-benzodioxol-5-yl)-1H-pyrazol-3-yl]-2-N-[1-(2,4-difluorophenyl)ethyl]-1,3,5-triazine-2,4-diamine;2-N-[1-(2,4-difluorophenyl)ethyl]-4-N-[5-(3,4-dimethoxyphenyl)-1H-pyrazol-3-yl]-1,3,5-triazine-2,4-diamine;2-N-[1-(2,4-difluorophenyl)ethyl]-4-N-[5-(2-fluorophenyl)-1H-pyrazol-3-yl]-1,3,5-triazine-2,4-diamine;2-N-[1-(2,4-difluorophenyl)ethyl]-4-N-[5-(3-fluorophenyl)-1H-pyrazol-3-yl]-1,3,5-triazine-2,4-diamine;2-N-[1-(2,4-difluorophenyl)ethyl]-4-N-[5-(4-fluorophenyl)-1H-pyrazol-3-yl]-1,3,5-triazine-2,4-diamine;2-N-[(1S)-1-(2,4-difluorophenyl)ethyl]-4-N-(5-quinoxalin-6-yl-1H-pyrazol-3-yl)-1,3,5-triazine-2,4-diamine.
Molecular Properties
| Compound Name | 4-N-[5-(1,3-benzodioxol-5-yl)-1H-pyrazol-3-yl]-2-N-[1-(2,4-difluorophenyl)ethyl]-1,3,5-triazine-2,4-diamine;2-N-[1-(2,4-difluorophenyl)ethyl]-4-N-[5-(3,4-dimethoxyphenyl)-1H-pyrazol-3-yl]-1,3,5-triazine-2,4-diamine;2-N-[1-(2,4-difluorophenyl)ethyl]-4-N-[5-(2-fluorophenyl)-1H-pyrazol-3-yl]-1,3,5-triazine-2,4-diamine;2-N-[1-(2,4-difluorophenyl)ethyl]-4-N-[5-(3-fluorophenyl)-1H-pyrazol-3-yl]-1,3,5-triazine-2,4-diamine;2-N-[1-(2,4-difluorophenyl)ethyl]-4-N-[5-(4-fluorophenyl)-1H-pyrazol-3-yl]-1,3,5-triazine-2,4-diamine;2-N-[(1S)-1-(2,4-difluorophenyl)ethyl]-4-N-(5-quinoxalin-6-yl-1H-pyrazol-3-yl)-1,3,5-triazine-2,4-diamine |
|---|---|
| PubChem CID | 159964486 |
| Molecular Formula | C125H103F15N44O4 |
| Molecular Weight | 2570.47 g/mol |
| Exact Mass | 2568.90 |
| IUPAC Name | 4-N-[5-(1,3-benzodioxol-5-yl)-1H-pyrazol-3-yl]-2-N-[1-(2,4-difluorophenyl)ethyl]-1,3,5-triazine-2,4-diamine;2-N-[1-(2,4-difluorophenyl)ethyl]-4-N-[5-(3,4-dimethoxyphenyl)-1H-pyrazol-3-yl]-1,3,5-triazine-2,4-diamine;2-N-[1-(2,4-difluorophenyl)ethyl]-4-N-[5-(2-fluorophenyl)-1H-pyrazol-3-yl]-1,3,5-triazine-2,4-diamine;2-N-[1-(2,4-difluorophenyl)ethyl]-4-N-[5-(3-fluorophenyl)-1H-pyrazol-3-yl]-1,3,5-triazine-2,4-diamine;2-N-[1-(2,4-difluorophenyl)ethyl]-4-N-[5-(4-fluorophenyl)-1H-pyrazol-3-yl]-1,3,5-triazine-2,4-diamine;2-N-[(1S)-1-(2,4-difluorophenyl)ethyl]-4-N-(5-quinoxalin-6-yl-1H-pyrazol-3-yl)-1,3,5-triazine-2,4-diamine |
| SMILES | CC(Nc1ncnc(Nc2cc(-c3ccc(F)cc3)[nH]n2)n1)c1ccc(F)cc1F.CC(Nc1ncnc(Nc2cc(-c3ccc4c(c3)OCO4)[nH]n2)n1)c1ccc(F)cc1F.CC(Nc1ncnc(Nc2cc(-c3cccc(F)c3)[nH]n2)n1)c1ccc(F)cc1F.CC(Nc1ncnc(Nc2cc(-c3ccccc3F)[nH]n2)n1)c1ccc(F)cc1F.COc1ccc(-c2cc(Nc3ncnc(NC(C)c4ccc(F)cc4F)n3)n[nH]2)cc1OC.C[C@H](Nc1ncnc(Nc2cc(-c3ccc4nccnc4c3)[nH]n2)n1)c1ccc(F)cc1F |
| InChI | InChI=1S/C22H17F2N9.C22H21F2N7O2.C21H17F2N7O2.3C20H16F3N7/c1-12(15-4-3-14(23)9-16(15)24)29-21-27-11-28-22(31-21)30-20-10-18(32-33-20)13-2-5-17-19(8-13)26-7-6-25-17;1-12(15-6-5-14(23)9-16(15)24)27-21-25-11-26-22(29-21)28-20-10-17(30-31-20)13-4-7-18(32-2)19(8-13)33-3;1-11(14-4-3-13(22)7-15(14)23)26-20-24-9-25-21(28-20)27-19-8-16(29-30-19)12-2-5-17-18(6-12)32-10-31-17;1-11(15-7-6-14(22)8-16(15)23)26-19-24-10-25-20(28-19)27-18-9-17(29-30-18)12-2-4-13(21)5-3-12;1-11(15-6-5-14(22)8-16(15)23)26-19-24-10-25-20(28-19)27-18-9-17(29-30-18)12-3-2-4-13(21)7-12;1-11(13-7-6-12(21)8-16(13)23)26-19-24-10-25-20(28-19)27-18-9-17(29-30-18)14-4-2-3-5-15(14)22/h2-12H,1H3,(H3,27,28,29,30,31,32,33);4-12H,1-3H3,(H3,25,26,27,28,29,30,31);2-9,11H,10H2,1H3,(H3,24,25,26,27,28,29,30);3*2-11H,1H3,(H3,24,25,26,27,28,29,30)/t12-;;;;;/m0...../s1 |
| InChIKey | ODTGMGQNXATARW-SXZTZMMXSA-N |
| XLogP | 26.85 |
| TPSA | 611.16 Ų |
| H-Bond Donors | 18 |
| H-Bond Acceptors | 42 |
| Rotatable Bonds | 38 |
| Heavy Atoms | 188 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2570.47 |
| LogP ≤ 5 | 26.85 |
| H-Bond Donors ≤ 5 | 18 |
| H-Bond Acceptors ≤ 10 | 42 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159964486 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.